From: Health benefits of electrically-assisted cycling: a systematic review
Study | Outcomes | Results, mean, SD (95% CI) | ||||
---|---|---|---|---|---|---|
Intervention | Control | Significance, p-value | ||||
Pre | Post | Pre | Post | |||
 |  | E-bike |  |  | ||
Cooper, 2018 [32] | Max absolute power | 157.5 (55.7) | 174.3 (70.8) | Â | Â | NC |
Men | 182.1 (51.5) | 206.2 (64.9) | Â | Â | NC | |
Women | 118.9 (38.9) | 124.3 (49.0) | Â | Â | NC | |
 |  | E-bike | NE | Within groups | ||
De Geus, 2013 [29] | Absolute VO2peak | Â | Â | Â | Â | Â |
Men | 2.56 (0.35) | 2.61 (0.38) | 2.62 (0.46) | 2.56 (0.35) | >.0.025 E-bike, NE | |
Women | 1.94 (0.37) | 2.07 (0.41) | 1.91 (0.35) | 1.94 (0.37) | >.0.025 E-bike, NE | |
Relative VO2peak | Â | Â | Â | Â | Â | |
Men | 30.2 (4.3) | 30.7 (5.6) | 30.8 (4.9) | 30.2 (4.3) | >.0.025 E-bike, NE | |
Women | 30.0 (6.0) | 32.3 (6.5) | 29.4 (5.1) | 30.0 (6.0) | >.0.025 E-bike, NE | |
Absolute max power | Â | Â | Â | Â | ||
Men | 169.5 (19.9) | 192.1 (28.7) | 173.8 (27.1) | 169.5 (19.9) | <.0.025 E-bike, >.0.025 NE | |
Women | 130.9 (21.6) | 145.9 (24.8) | 131.1 (21.7) | 130.9 (21.6) | <.0.025 E-bike, >.0.025 NE | |
Relative max power | Â | Â | Â | Â | Â | |
Men | 2.00 (0.28) | 2.30 (0.40) | 2.05 (0.35) | 2.00 (0.28) | <.0.025 E-bike, >.0.025 NE | |
Women | 2.03 (0.41) | 2.30 (0.55) | 2.04 (0.43) | 2.03 (0.41) | <.0.025 E-bike, >.0.025 NE | |
 |  | E-bike | CB |  | ||
Hochsmann, 2017 [30] | Relative VO2peak | 35.7 (5.8) | 39.3 (8.3) | 36.4 (7.3) | 38.6 (6.2) | 0.327, 1.4 (− 1.4–4.1)+ |
Relative power output | 2.9 (0.6) | 3.2 (0.6) | 3 (0.5) | 3.3 (0.5) | 0.995, 0.0 (− 0.1–0.1)+ | |
Resting HR | 64.7 (6.5) | 65.1 (7.6) | 68.8 (8.8) | 65.5 (10.6) | 0.505, 2.0 (−4.2–8.2) + | |
HR at 100 W max text | 113.4 (9.2) | 111.5 (7.7) | 113.4 (15.9) | 109.2 (14.2) | 0.219, 2.4 (− 1.5–6.2) + | |
SBP at rest | 125.9 (13.8) | 124.1 (11.3) | 127.3 (10.6) | 123.1 (12.4) | 0.538, 2.0 (−4.5–8.5) + | |
DBP at rest | 82.4 (8.5) | 82.1 (8.2) | 87.7 (8) | 84.5 (8.8) | 0.625, 1.2 (−3.9–6.3) + | |
SBP @ 100 W | 174.1 (22.9) | 160.3 (21.2) | 160.8 (20) | 150.4 (18.5) | 0.93, −0.4 (−9.4–8.7) + | |
DBP @ 100 W | 86.2 (8.3) | 81.9 (6.5) | 88 (7.1) | 84 (8.1) | 0.709, −1.1 (−7.5–5.2) + | |
 |  | E-bike |  |  |  | |
Malnes, 2016 [31] | Relative VO2peak | 34.1 (31.6, 36.7) | 36.5 (34.4, 38.6) | Â | Â | <.001 |
Relative VO2peak, % gain | Â | 7.7 (4.3, 11.1) | Â | Â | Â | |
High Fitness |  | 1.5 (−5.6, 8.6) |  |  | 0.626 | |
Low Fitness | Â | 9.6 (5.9, 13.3) | Â | Â | <.05 | |
Peak HR | 181 (175, 187) | 180 (174, 186) | Â | Â | 0.429 | |
 |  | E-bike commute | Passive commute |  |  | |
Page, 2017 [33] | QOL (baseline and week 8) | 38.00 (3.86) | 39.67 (4.47) | 29.63 (6.57) | 35.71 (5.59) | >.05 E-bike, Passive commute |
OQL (week 4) |  | 38.84 (4.16) |  | 32.67 (6.08) | <.01, ES = 0.28 | |
 |  | E-bike |  |  |  | |
Peterman, 2016 [13] | Absolute VO2max | 2.21 (0.48) | 2.39 (0.52) | Â | Â | <.05 |
MVPA | 28.1 (17.5) | 29.0 (20.2) | Â | Â | >.05 | |
MVPA10+ | 11.7 (14.3) | 13.0 (15.2) | Â | Â | >.05 | |
Absolute max power | 165.1 (37.1) | 189.3 (38.3) | Â | Â | <.05 | |
Fasting glucose | 4.99 (0.52) | 5.02 (0.47) | Â | Â | >.05 | |
2 h post plasma glucose | 5.53 (1.18) | 5.03 (0.91) |  |  | <.05 | |
HOMA | 2.46 (0.95) | 2.55 (0.82) | Â | Â | >.05 | |
Total cholesterol | 3.90 (0.87) | 3.92 (0.79) | Â | Â | >.05 | |
LDL | 2.33 (0.8) | 2.34 (0.71) | Â | Â | >.05 | |
HDL | 1.21 (0.24) | 1.18 (0.22) | Â | Â | >.05 | |
Triglycerides | 0.95 (0.42) | 0.91 (0.27) | Â | Â | >.05 | |
MAP | 84.6 (10.5) | 83.2 (9.4) | Â | Â | >.05 | |
SBP | 110.0 (12.4) | 109.1 (10.9) | Â | Â | >.05 | |
DBP | 67.7 (8.8) | 67.0 (8.0) | Â | Â | >.05 |